TTPH
Goldman Sachs’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-380,978
| Closed | -$183K | – | 4393 |
|
|
2019
Q2 | $183K | Buy |
380,978
+253,398
| +199% | +$122K | ﹤0.01% | 3903 |
|
|
2019
Q1 | $171K | Sell |
127,580
-78,922
| -38% | -$106K | ﹤0.01% | 3924 |
|
|
2018
Q4 | $233K | Buy |
206,502
+2,584
| +1% | +$2.92K | ﹤0.01% | 3689 |
|
|
2018
Q3 | $563K | Sell |
203,918
-1,667
| -0.8% | -$4.6K | ﹤0.01% | 3416 |
|
|
2018
Q2 | $734K | Buy |
205,585
+95,770
| +87% | +$342K | ﹤0.01% | 3352 |
|
|
2018
Q1 | $337K | Buy |
109,815
+37,291
| +51% | +$114K | ﹤0.01% | 3660 |
|
|
2017
Q4 | $457K | Buy |
72,524
+25,473
| +54% | +$161K | ﹤0.01% | 3493 |
|
|
2017
Q3 | $322K | Buy |
+47,051
| New | +$322K | ﹤0.01% | 3695 |
|
|
2017
Q2 | – | Sell |
-15,337
| Closed | -$141K | – | 4583 |
|
|
2017
Q1 | $141K | Sell |
15,337
-16,258
| -51% | -$149K | ﹤0.01% | 4032 |
|
|
2016
Q4 | $127K | Sell |
31,595
-10,085
| -24% | -$40.5K | ﹤0.01% | 4041 |
|
|
2016
Q3 | $160K | Sell |
41,680
-25,622
| -38% | -$98.4K | ﹤0.01% | 4020 |
|
|
2016
Q2 | $289K | Sell |
67,302
-41,891
| -38% | -$180K | ﹤0.01% | 3641 |
|
|
2016
Q1 | $506K | Sell |
109,193
-139,874
| -56% | -$648K | ﹤0.01% | 3217 |
|
|
2015
Q4 | $2.5M | Buy |
249,067
+228,309
| +1,100% | +$2.29M | ﹤0.01% | 2407 |
|
|
2015
Q3 | $155K | Buy |
20,758
+11,046
| +114% | +$82.5K | ﹤0.01% | 3982 |
|
|
2015
Q2 | $461K | Buy |
+9,712
| New | +$461K | ﹤0.01% | 3403 |
|
|
2014
Q4 | – | Sell |
-15,867
| Closed | -$317K | – | 4737 |
|
|
2014
Q3 | $317K | Buy |
+15,867
| New | +$317K | ﹤0.01% | 3626 |
|
|
2014
Q2 | – | Sell |
-26,943
| Closed | -$293K | – | 4542 |
|
|
2014
Q1 | $293K | Sell |
26,943
-503
| -2% | -$5.47K | ﹤0.01% | 3697 |
|
|
2013
Q4 | $371K | Buy |
+27,446
| New | +$371K | ﹤0.01% | 3593 |
|